{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:08:14Z","timestamp":1761059294716},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T00:00:00Z","timestamp":1331251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1752-1947-6-81","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T10:14:32Z","timestamp":1331288072000},"source":"Crossref","is-referenced-by-count":5,"title":["Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report"],"prefix":"10.1186","volume":"6","author":[{"given":"Masatoshi","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihisa","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Funahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daizo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomone","family":"Shioura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihisa","family":"Kanamono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,9]]},"reference":[{"key":"2041_CR1","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.addr.2004.01.012","volume":"56","author":"CM Paulos","year":"2004","unstructured":"Paulos CM, Turk MJ, Breur GJ, Low PS: Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv Drug Deliv Rev. 2004, 56: 1205-1217. 10.1016\/j.addr.2004.01.012.","journal-title":"Adv Drug Deliv Rev"},{"key":"2041_CR2","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2009.181","volume":"5","author":"PC Taylor","year":"2009","unstructured":"Taylor PC, Feldmann M: Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat Rev Rheumatol. 2009, 5: 578-582. 10.1038\/nrrheum.2009.181.","journal-title":"Nat Rev Rheumatol"},{"key":"2041_CR3","first-page":"344","volume":"66","author":"A Lohse","year":"1999","unstructured":"Lohse A, Despaux J, Auge B, Toussirot E, Wendling D: Pneumococcal polyarticular septic arthritis in a patient with rheumatoid arthritis. Rev Rhum Engl Ed. 1999, 66: 344-346.","journal-title":"Rev Rhum Engl Ed"},{"key":"2041_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/s10165-006-0532-0","volume":"17","author":"H Yamanaka","year":"2007","unstructured":"Yamanaka H, Tanaka Y, Sekiguchi N, Inoue E, Saito K, Kameda H, Iikuni N, Nawata M, Amano K, Shinozaki M, Takeuchi T: Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM). Mod Rheumatol. 2007, 17: 28-32. 10.1007\/s10165-006-0532-0.","journal-title":"Mod Rheumatol"},{"key":"2041_CR5","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1002\/art.21386","volume":"52","author":"J Listing","year":"2005","unstructured":"Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, Gromnica-Ihle E, Antoni C, Herzer P, Kekow J, Schneider M, Zink A: Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum. 2005, 52: 3403-3412. 10.1002\/art.21386.","journal-title":"Arthritis Rheum"},{"key":"2041_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/art.21734","volume":"54","author":"R Westhovens","year":"2006","unstructured":"Westhovens R, Yocum D, Han J, Berman A, Strusberg I, Geusens P, Rahman MU, START Study Group: The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial. Arthritis Rheum. 2006, 54: 1075-1086. 10.1002\/art.21734.","journal-title":"Arthritis Rheum"},{"key":"2041_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/ard.2007.072967","volume":"67","author":"T Takeuchi","year":"2008","unstructured":"Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro N, Tanaka Y, Yamanaka H, Kamatani N, Harigai M, Ryu J, Inoue K, Kondo H, Inokuma S, Ochi T, Koike T: Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 189-94. 10.1136\/ard.2007.072967.","journal-title":"Ann Rheum Dis"},{"key":"2041_CR8","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/art.10529","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE: Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002, 46: 2294-2300. 10.1002\/art.10529.","journal-title":"Arthritis Rheum"},{"key":"2041_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.autrev.2011.04.010","volume":"10","author":"H Rosenblum","year":"2011","unstructured":"Rosenblum H, Amital H: Anti-TNF therapy: safety aspects of taking the risk. Autoimmun Rev. 2011, 10: 563-568. 10.1016\/j.autrev.2011.04.010.","journal-title":"Autoimmun Rev"},{"key":"2041_CR10","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/art.21978","volume":"54","author":"WG Dixon","year":"2006","unstructured":"Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP: Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2006, 54: 2368-2376. 10.1002\/art.21978.","journal-title":"Arthritis Rheum"},{"key":"2041_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jbspin.2005.07.004","volume":"73","author":"E Forestier","year":"2006","unstructured":"Forestier E, Sordet C, Cohen-Solal J, Remy V, Javier RM, Kuntz JL, Sibilia J: Bone and joint infection due to Streptococcus pneumoniae in two immunocompetent adults. Joint Bone Spine. 2006, 73: 325-8. 10.1016\/j.jbspin.2005.07.004.","journal-title":"Joint Bone Spine"},{"key":"2041_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1086\/345954","volume":"36","author":"JJ Ross","year":"2003","unstructured":"Ross JJ, Saltzman CL, Carling P, Shapiro DS: Pneumococcal septic arthritis: review of 190 cases. Clin Infect Dis. 2003, 36: 319-327. 10.1086\/345954.","journal-title":"Clin Infect Dis"},{"key":"2041_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.semarthrit.2004.04.002","volume":"34","author":"J Raad","year":"2004","unstructured":"Raad J, Peacock JE: Septic arthritis in the adult caused by Streptococcus pneumoniae: a report of 4 cases and review of the literature. Semin Arthritis Rheum. 2004, 34: 559-569. 10.1016\/j.semarthrit.2004.04.002.","journal-title":"Semin Arthritis Rheum"},{"key":"2041_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1297-319X(03)00122-2","volume":"71","author":"JJ Dubost","year":"2004","unstructured":"Dubost JJ, Soubrier M, De Champs C, Ristori JM, Sauvezie B: Streptococcal septic arthritis in adults. A study of 55 cases with a literature review. Joint Bone Spine. 2004, 71: 303-311. 10.1016\/S1297-319X(03)00122-2.","journal-title":"Joint Bone Spine"},{"key":"2041_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jbspin.2004.08.005","volume":"72","author":"NH Sewlall","year":"2005","unstructured":"Sewlall NH, Tikly M: Invasive pneumococcal infection presenting as septic arthritis and Austrian-like syndrome involving the tricuspid valve in a patient with underlying HIV infection. Joint Bone Spine. 2005, 72: 86-88. 10.1016\/j.jbspin.2004.08.005.","journal-title":"Joint Bone Spine"},{"key":"2041_CR16","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1136\/ard.2011.152769","volume":"70","author":"JB Galloway","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Ustianowski AP, Helbert M, Watson KD, Lunt M, Symmons DP, BSR Biologics Register: Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2011, 70: 1810-1814. 10.1136\/ard.2011.152769.","journal-title":"Ann Rheum Dis"},{"key":"2041_CR17","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1086\/313526","volume":"29","author":"P Ispahani","year":"1999","unstructured":"Ispahani P, Weston VC, Turner DP, Donald FE: Septic arthritis due to Streptococcus pneumoniae in Nottingham, United Kingdom, 1985-1998. Clin Infect Dis. 1999, 29: 1450-1454. 10.1086\/313526.","journal-title":"Clin Infect Dis"},{"key":"2041_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1056\/NEJM199309303291407","volume":"329","author":"DG Baker","year":"1993","unstructured":"Baker DG, Schumacher HR: Acute monoarthritis. N Engl J Med. 1993, 329: 1013-1020. 10.1056\/NEJM199309303291407.","journal-title":"N Engl J Med"},{"key":"2041_CR19","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/rheumatology\/36.3.370","volume":"36","author":"MJ Ryan","year":"1997","unstructured":"Ryan MJ, Kavanagh R, Wall PG, Hazleman BL: Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol. 1997, 36: 370-373. 10.1093\/rheumatology\/36.3.370.","journal-title":"Br J Rheumatol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-6-81\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-6-81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-6-81","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-6-81.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:48:21Z","timestamp":1548118101000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-6-81"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,9]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2041"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-6-81","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,9]]},"article-number":"81"}}